1. Home
  2. Programs
  3. Clinician's Roundtable

Psychoactive Drug Research: What's New with Hallucinogens?

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
  • Overview

    It used to be common for researchers to study the potential medicinal uses for hallucinogenic drugs, including psilocybin, ecstasy, and LSD; however, the 60's left a blemish on legitimate research and it grinded to a halt. Host Dr. Leslie Lundt welcomes Dr. Matthew Johnson, a psychopharmacologist in the Department of Psychiatry at the Johns Hopkins School of Medicine, who is studying psychoactive drug effects in human participants.

Recommended
Details
Presenters
  • Overview

    It used to be common for researchers to study the potential medicinal uses for hallucinogenic drugs, including psilocybin, ecstasy, and LSD; however, the 60's left a blemish on legitimate research and it grinded to a halt. Host Dr. Leslie Lundt welcomes Dr. Matthew Johnson, a psychopharmacologist in the Department of Psychiatry at the Johns Hopkins School of Medicine, who is studying psychoactive drug effects in human participants.

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free